Safety of Ataciguat in Patients With Moderate Calcific Aortic Valve Stenosis

Completed · Phase 1 · Has a placebo group

Conditions studied: Aortic Valve Stenosis

In brief

This study will determine whether Ataciguat (HMR1766) is well-tolerated in patients with mild to moderate calcific aortic valve stenosis. The primary focus of these studies will be on changes in blood pressure and orthostatic tolerance (i.e., ability to stand up without passing out), and determining whether treatment with Ataciguat results in significant reductions in blood pressure in this patient population.

Key facts

Study ID
NCT02049203
Run by
Jordan D. Miller, Ph.D.
People needed
44
Starts
2014-01-01
Expected to finish
2015-03-01
Last updated by the study team
2016-07-07

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.